India gets emergency use nod for first indigenous mRNA vaccine against Covid
2 years, 6 months ago

India gets emergency use nod for first indigenous mRNA vaccine against Covid

Live Mint  

The Drugs Controller General of India on Tuesday approved India's first home-grown mRNA Covid-19 vaccine by Gennova Biopharma for emergency use in 18 years and above. While other mRNA vaccines require to be stored at sub-zero temperatures, Gennova's mRNA vaccine can be stored at 2-8 degrees. The Subject Expert Committee in a meeting held on Friday recommended Emergency Use Authorisation for the mRNA vaccine against Covid-19. "Product development using innovative technologies like mRNA, a fourth-generation vaccine platform stable at 2 to 8 degrees Celcius, is a challenging journey during pandemic times," the spokesperson further said.

India Data Covid Cells Protein Vaccine Emergency Use Gennova Indigenous Mrna  india  emergency  vaccines  data  gets  vaccine  covid  protein  indigenous  mrna  phase  covid19  nod  cells  spike  piece

History of this topic

Recent breakthrough in COVID-19 vaccination: Indian Immunologicals Ltd unveils first needle-free booster vaccine
4 months, 1 week ago

Recent breakthrough in COVID-19 vaccination: Indian Immunologicals Ltd unveils first needle-free booster vaccine

Hindustan Times  

In a recent development, Hyderabad-based Indian Immunologicals Ltd in collaboration with Griffith University in Australia has made a significant breakthrough in COVID-19 vaccination technology. Indian Immunologicals Ltd unveils first needle-free booster vaccine “This accomplishment signifies a major step forward in our battle against COVID-19. According to the press release, the innovative vaccine sports an attenuated formulation that uses advanced codon …

With State prod, India can be world leader in vaccines
11 months, 2 weeks ago

With State prod, India can be world leader in vaccines

Hindustan Times  

The World Health Organization activated its incident management support team as part of its emergency response framework on the emergence of a cluster of atypical pneumonia cases emerging from Wuhan, China, on January 1, 2020. India, the dark horse in the vaccine race, did the unexpected and against all odds, approving EUA to two vaccines — “made in India” Covishield …

A new regime: On the Emergency Use Authorisation regime in India and clinical trials
1 year, 6 months ago

A new regime: On the Emergency Use Authorisation regime in India and clinical trials

The Hindu  

Last week, the Drug Controller General of India cleared, under the provisions of ‘emergency use authorisation’, a new mRNA vaccine for COVID-19 developed by Pune-based Gennova Biopharmaceuticals, a pioneer in India in developing mRNA vaccines. More than evidence-based assessment, it was a technicality in India’s ‘New Drugs and Clinical Trials Rules, 2019’ that allowed EUA in India for COVID-19 vaccines. …

India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose
1 year, 6 months ago

India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose

The Hindu  

India’s first indigenously developed mRNA vaccine against the dominant Omicron variant of the COVID-19 coronavirus will cost ₹2,292, Sanjay Singh, CEO, Gennova Biopharmaceuticals, said at a press conference on June 24. The vaccine will for now only be available as a booster or “precaution dose”, that is, somebody who has already been vaccinated thrice will be ineligible as the relevant …

First Omicron-specific mRNA vaccine from India approved by regulators
1 year, 6 months ago

First Omicron-specific mRNA vaccine from India approved by regulators

The Hindu  

India’s first indigenous mRNA vaccine for the Omicron variant, GEMCOVAC-OM, developed by Pune-based Gennova Biopharmaceuticals Ltd, was approved under emergency use guidelines by the Drug Controller General of India late Monday. Gennova CEO Sanjay Singh said that by the time his company got regulatory approvals for GEMCOVAC-19, the demand for primary doses was largely met by other vaccines, however there …

Covid vaccine mission is a lesson for the world
1 year, 10 months ago

Covid vaccine mission is a lesson for the world

Hindustan Times  

When Covid-19 began in early 2020, most experts predicted India could face disastrous consequences. India’s response to the pandemic highlighted the underlying strengths of our scientific and technological prowess Not only did India succeed in protecting its population, but it also sent vaccines to other countries, thus proving to the world its capability of developing the first-ever DNA vaccine and …

COVID-19: 3 lakh doses of intranasal vaccine iNCOVACC sent to hospitals, says Bharat Biotech's Krishna Ella
1 year, 11 months ago

COVID-19: 3 lakh doses of intranasal vaccine iNCOVACC sent to hospitals, says Bharat Biotech's Krishna Ella

India TV News  

COVID-19 vaccine : Bharat Biotech dispatched three lakh doses of its intranasal COVID-19 vaccine to some hospitals two days ago, the company's executive chairman Krishna Ella said on Sunday. "We dispatched three lakh doses of the world's first intranasal COVID-19 vaccine to some hospitals two days ago," Ella said. Establishing the UW-Madison Global One Health Centre holds great significance as …

Over 7,000 Doses of Bharat Biotech's Intranasal Jab Ready for Market Rollout as Apex Lab Clears Batch 1
1 year, 11 months ago

Over 7,000 Doses of Bharat Biotech's Intranasal Jab Ready for Market Rollout as Apex Lab Clears Batch 1

News 18  

Over 7,000 doses of the world’s first intranasal Covid-19 vaccine, Bharat Biotech’s iNCOVACC, have been checked and released by the country’s apex vaccine testing laboratory, News18.com has learnt. BBV154, a novel adenovirus vectored intranasal vaccine for Covid-19, was sent to CDL in the first week of January in around six batches containing 15,000 doses. In polio, the dropper drops the …

India launches world’s 1st intranasal Covid vaccine: Check price, availability
1 year, 11 months ago

India launches world’s 1st intranasal Covid vaccine: Check price, availability

Hindustan Times  

The world's first made-in-India intranasal Covid-19 vaccine iNCOVACC, manufactured by Bharat Biotech, was launched on Thursday as the country marked its 74th Republic Day. Union health minister Mansukh Mandaviya launched the vaccine and emphasised India's vaccine manufacturing and innovation capability, which he said is appreciated all over the world. "As the world's first intranasal Covid-19 vaccine, this is a glorious …

Health minister Mandaviya launches Bharat Biotech's nasal Covid vaccine
1 year, 11 months ago

Health minister Mandaviya launches Bharat Biotech's nasal Covid vaccine

Hindustan Times  

Union Health Minister Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launched Bharat Biotech's nasal Covid vaccine, iNCOVACC, on the occasion of Republic Day on Thursday. The nasal vaccine -- BBV154 -- had received the Drugs Controller General of India's approval in November for restricted emergency use among adults as a heterologous booster dose. According to a statement issued …

India’s first intra-nasal Covid-19 vaccine iNCOVACC launched
1 year, 11 months ago

India’s first intra-nasal Covid-19 vaccine iNCOVACC launched

Live Mint  

Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launched India's first made nasal vaccine against Covid-19 iNCOVACC. "Our nasal vaccine will be officially launched on January 26, on Republic Day," the company's chairman and managing director Krishna Ella said, participating in the 'Face-to-Face with New Frontiers in Science' segment of the IISF, organised at the …

COVID-19: Mansukh Mandaviya launches world's 1st Made-in-India nasal vaccine iNCOVACC
1 year, 11 months ago

COVID-19: Mansukh Mandaviya launches world's 1st Made-in-India nasal vaccine iNCOVACC

India TV News  

COVID-19 nasal vaccine launch : Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh collectively launched 'iNCOVACC', the world's first made-in-India nasal vaccine on Thursday in the national capital. Who all were present: On the occasion of the launch, the Union Minister of State Science & Technology; Minister of State Earth Sciences; MoS PMO, Personnel, Public …

First Indian intranasal Covid vaccine by Bharat Biotech to be launched on Jan 26
1 year, 11 months ago

First Indian intranasal Covid vaccine by Bharat Biotech to be launched on Jan 26

India TV News  

Homegrown vaccine maker Bharat Biotech will launch its intranasal COVID-19 vaccine iNCOVACC, the first of its kind in India, on January 26, the company's chairman and managing director Krishna Ella said here on Saturday. In December, Bharat Biotech had announced that it would sell the intranasal vaccine for Rs 325 per shot for procurement by the government and Rs 800 …

Time to Join this ‘Herd’: 39% Have Boosted Their Protection against Covid Virus, Finds Survey
1 year, 11 months ago

Time to Join this ‘Herd’: 39% Have Boosted Their Protection against Covid Virus, Finds Survey

News 18  

At least 39% of respondents have already taken the Covid vaccine booster dose, while 6% plan to take the injectable booster and 4% the nasal one, a LocalCircles survey has found. Amid the uptick in Covid in cases in China and other countries, the Centre gave nod for Bharat Biotech’s intranasal COVID vaccine iNCOVAAC as a booster dose. Director General …

Braving a Viral Storm tells the tale of India’s COVID vaccine journey
2 years ago

Braving a Viral Storm tells the tale of India’s COVID vaccine journey

The Hindu  

India’s development and production of its own vaccines against COVID-19 was an important part of dealing with the pandemic, pushed by Prime Minister Narendra Modi’s view that the “entrepreneurial state” of government would bear the front-loaded risks of the effort, cushioning the private sector, according to a new book. The authors of Braving a Viral Storm: India’s Covid-19 Vaccine Story, …

Staying prepared: On scaling up the pace of COVID-19 genome sequencing
2 years ago

Staying prepared: On scaling up the pace of COVID-19 genome sequencing

The Hindu  

Three years after strict enforcement of its Zero-COVID strategy, China abandoned it abruptly, leading to a jump in cases each day — an estimated 250 million people were infected in 20 days in December, according to the media, overwhelming hospitals and crematoria. Though this variant was found in many countries, including India, months ago, there is fear that the uncontrolled …

Bharat Biotech’s intranasal covid vaccine priced at ₹325 for govt hospitals
2 years ago

Bharat Biotech’s intranasal covid vaccine priced at ₹325 for govt hospitals

Live Mint  

NEW DELHI: Bharat Biotech’s intranasal covid-19 vaccine--iNCOVACC --will be available for ₹325 per dose at government hospitals, and for ₹800 in private settings, the pharma major said on Tuesday. According to the company, iNCOVACC is the world’s first intranasal vaccine for covid-19 to have received approval for a primary two-dose schedule, and as a heterologous booster dose. Clinical trials were …

COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN
2 years ago

COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN

Firstpost  

The needle-free vaccine will be available at private centres. It will be introduced on the Co-WIN platform on Friday evening New Delhi: Bharat Biotech’s intranasal COVID-19 vaccine has been approved by the Ministry of Health and Family Welfare for inclusion in the vaccination programme as a booster dose for those above 18 years of age, official sources said on Thursday. …

Indian Army issues advisory on Covid, asks defence personnel to take safety measures
2 years ago

Indian Army issues advisory on Covid, asks defence personnel to take safety measures

India TV News  

The Indian Army issued an advisory on Friday asking defence personnel to take up adequate measures to tackle COVID. The advisory asked them to take up measures such as the usage of face masks in closed or crowded places, practising hand sanitisation, and maintaining social distancing among others. Union Health Minister Dr Mansukh Mandaviya is set to hold a virtual …

World’s first intra-nasal vaccine for COVID gets CDSCO nod for restricted use
2 years, 1 month ago

World’s first intra-nasal vaccine for COVID gets CDSCO nod for restricted use

Live Mint  

World's first intra-nasal vaccine for COVID developed by India has got approval from the Central Drugs Standard Control Organisation for restricted use in emergency situations in the age group of 18 and above. A press release from the vaccine maker said iNCOVACC, a recombinant replication deficient adenovirus vectored vaccine with a pre-fusion stabilised SARS-CoV-2 spike protein, is the world's first …

What Makes India's Covid Vaccination Programme A Global Best Practice In Public Health
2 years, 1 month ago

What Makes India's Covid Vaccination Programme A Global Best Practice In Public Health

News 18  

On April 14, 2020, India’s Prime Minister made an appeal to scientists and researchers to take the lead in developing a vaccine against the coronavirus. The group was tasked with formulating an implementation strategy for the Covid-19 vaccine including the selection of vaccine candidates, procurement of vaccines, prioritisation of population groups for vaccination, enabling digital infrastructure, vaccine delivery platforms as …

Health Ministry not to procure fresh COVID-19 vaccines; surrenders ₹4,237 crore from vaccination budget
2 years, 2 months ago

Health Ministry not to procure fresh COVID-19 vaccines; surrenders ₹4,237 crore from vaccination budget

The Hindu  

The government’s COVID-19 vaccination programme is in its final leg with the Health Ministry deciding against procuring more vaccines as of now and surrendering ₹4,237 crore, or nearly 85% of the 2022-23 budget allocation for inoculation purposes, to the Finance Ministry. Official sources told PTI that more than 1.8 crore doses are still available with the governments at the Centre …

How the COVID-19 pandemic altered the vaccine story in India
2 years, 2 months ago

How the COVID-19 pandemic altered the vaccine story in India

The Hindu  

Last week, Twitter temporarily blocked a post by Florida’s surgeon general Joseph A. Ladapo. Such DNA vaccines, older in provenance than mRNA vaccines, involve inserting DNA for an antigen — or the part of the virus that stimulates the immune system — into a special kind of circular DNA called plasmids that are usually only found in bacteria. In the …

Will Two ‘Made-in-India’ Vaccines Be the New Covid Boosters? News18 Decodes Differences
2 years, 3 months ago

Will Two ‘Made-in-India’ Vaccines Be the New Covid Boosters? News18 Decodes Differences

News 18  

India will soon roll out mRNA shots and intranasal vaccines, which will be available on CoWIN, and can be used as boosters against Covid-19. India’s first mRNA shot is only the third mRNA vaccine to be approved for Covid-19 in the world after Pfizer and Moderna. But mortality will be reduced.” Sharing a study of the intranasal vaccines under clinical …

India and China clear needle-free COVID-19 vaccines
2 years, 4 months ago

India and China clear needle-free COVID-19 vaccines

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. CanSino Biologics announced Sunday that Chinese regulators have approved …

Bharat Biotech’s intra-nasal COVID vaccine gets emergency use approval
2 years, 4 months ago

Bharat Biotech’s intra-nasal COVID vaccine gets emergency use approval

The Hindu  

Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 recombinant nasal vaccine has been approved by Central Drugs Standard Control Organisation for primary immunization against COVID-19 in 18+ age group for restricted use in emergencies, Health Minister Mansukh Mandaviya tweeted on Tuesday. Dr. Krishna Ella, chairman and managing director, Bharat Biotech, said: “iNCOVACC will be a global game changer in intra-nasal vaccines technology and delivery …

India's First Nasal Vaccine for Covid-19, Made by Bharat Biotech, Cleared for Emergency Use
2 years, 4 months ago

India's First Nasal Vaccine for Covid-19, Made by Bharat Biotech, Cleared for Emergency Use

News 18  

Bharat Biotech has been given an emergency use authorisation by India’s drug regulator, the Drug Controller General of India, for its intranasal Covid-19 vaccine, Union Health Minister Dr Mansukh Mandaviya tweeted on Tuesday. Big Boost to India's Fight Against COVID-19!Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for restricted …

Covid-19: India's first intranasal vaccine by Bharat Biotech gets DCGI approval
2 years, 4 months ago

Covid-19: India's first intranasal vaccine by Bharat Biotech gets DCGI approval

India TV News  

The Bharat Biotech on Tuesday got emergency use authorisation from the Drugs Controller General of India for the Intranasal Covid-19 vaccine. Union Minister of Health and Family Welfare Mansukh Mandaviya termed it a 'Big boost' to India's fight against Covid-19. Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 recombinant nasal vaccine approved by CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for …

An End to Foreign-return Vaccine Woes: India to Offer Remaining Covid-19 Shots Domestically
2 years, 4 months ago

An End to Foreign-return Vaccine Woes: India to Offer Remaining Covid-19 Shots Domestically

News 18  

Individuals who have received Covid-19 vaccines abroad and wish to get their second dose or booster shot in India can now do so. The development comes following an August 18 report by the Times of India which highlighted the issues people who had been jabbed abroad faced when they tried to receive a second or third shot here because the …

COVID-19: Corbevax to be given as boosters at vaccination centres from today
2 years, 5 months ago

COVID-19: Corbevax to be given as boosters at vaccination centres from today

Live Mint  

Hyderabad based-Biological E Ltd 's recently approved heterologous Covid-19 vaccine Corbevax to be available as a booster dose on the COWIN App in both public and private vaccination centres from 12 August, the firm said on 11 August. The Union Health Ministry approved Corbevax as India's first heterologous COVID-19 booster shot for 18 years and above after the six months …

Corbevax Likely to be Available As Covid Booster Dose at Vaccination Centres from Friday
2 years, 5 months ago

Corbevax Likely to be Available As Covid Booster Dose at Vaccination Centres from Friday

News 18  

Biological E. Ltd on Thursday said it has delivered 10 crore doses of its Covid-19 vaccine, Corbevax to the Centre so far which is expected to be available as a booster dose on the Cowin App in public and private vaccination centers from Friday. Corbevax was also approved by the Union Health Ministry as a heterologous Covid-19 booster dose under …

In A First, Biological E's Corbevax Approved As Covid Booster for Covishield, Covaxin Recipients
2 years, 5 months ago

In A First, Biological E's Corbevax Approved As Covid Booster for Covishield, Covaxin Recipients

News 18  

The Centre has approved Biological E’s Corbevax as a Covid-19 precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin. Union Health Secretary Rajesh Bhushan said, “Corbevax will be available as precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines …

Govt Nod for Corbevax as Booster for Adults Vaccinated with Covishield, Covaxin Soon
2 years, 5 months ago

Govt Nod for Corbevax as Booster for Adults Vaccinated with Covishield, Covaxin Soon

News 18  

The Union health ministry is expected to soon approve Biological E’s Corbevax as a precaution dose for people above 18 years who are double vaccinated with either Covishield or Covaxin, official sources said on Tuesday. “Corbevax will be considered as a precaution dose after completion of 6 months or 26 weeks from the date of administration of the second dose …

Bharat Biotech expects regulator’s nod for intranasal COVID-19 vaccine this month
2 years, 5 months ago

Bharat Biotech expects regulator’s nod for intranasal COVID-19 vaccine this month

The Hindu  

Bharat Biotech, which is working on an intranasal COVID-19 vaccine candidate is hopeful of getting regulatory licenses this month, if all goes well, Chairman and Managing Director of the company, Krishna Ella said. Clinical trials of nasal vaccine complete Mr. Ella said the firm completed clinical trials of the nasal vaccine with about 4,000 volunteers and there is no instance …

Data | Less than 4% Indians got COVID-19 booster dose, among lowest in the world
2 years, 5 months ago

Data | Less than 4% Indians got COVID-19 booster dose, among lowest in the world

The Hindu  

After reducing the gap between the second dose and the precautionary dose of the COVID-19 vaccine from nine to six months for adults, the government on Wednesday announced free booster shots for adults for the next 75 days. Strikingly, India’s progress in the administration of the first two doses was relatively better, with 65.5% of the population getting both shots, …

Free COVID-19 booster shots for all adults for 75 days from July 15 at government centres
2 years, 6 months ago

Free COVID-19 booster shots for all adults for 75 days from July 15 at government centres

The Hindu  

As part of the Azadi Ka Amrit Mahotsav celebrations, free precaution doses of COVID-19 vaccines will be available for all citizens above 18 years of age at government vaccination centres from July 15 for 75 days, Anurag Singh Thakur, Union Minister of Information and Broadcasting, announced on July 13, following a meeting of the Union Cabinet. India’s cumulative COVID-19 vaccination …

COVID-19 vaccine: Ashok Gehlot asks Centre to make 'precautionary dose' free amid rising coronavirus cases
2 years, 6 months ago

COVID-19 vaccine: Ashok Gehlot asks Centre to make 'precautionary dose' free amid rising coronavirus cases

India TV News  

Highlights Rajasthan CM urged Centre to provide precautionary dose free of cost to people aged 18-45 years Corona infection cases have increased across the country in the last few days, said CM Ashok Gehlot India on Apr 10 began administering precaution doses of COVID vaccines to all aged above 18 years COVID-19 vaccine news : Amid a rise in coronavirus …

Gennova Biopharmaceuticals' mRNA vaccine gets DCGI approval for emergency use
2 years, 6 months ago

Gennova Biopharmaceuticals' mRNA vaccine gets DCGI approval for emergency use

India TV News  

Highlights GEMCOVAC-19 is the first mRNA vaccine that has been developed in India The company will sell the vaccine under the brand name GEMCOVAC-19 The two-dose vaccine will be administered intramuscularly at 28 days apart India's first indigenously developed mRNA vaccine, GEMCOVAC-19, has been approved for emergency use by the Drug Controller General of India on Tuesday. The vaccine has …

India's first indigenous mRNA vaccine against Covid gets emergency use nod
2 years, 6 months ago

India's first indigenous mRNA vaccine against Covid gets emergency use nod

India Today  

The Drugs Controller General of India has given a green signal to the country’s first indigenous mRNA vaccine against Covid by Gennova Biopharma for emergency use among adults in India, said sources. While other mRNA vaccines require sub zero temperatures for storage, Gennova Biopharmaceuticals, a Pune-based company, claimed it will not need ultra-cold storages which could mean its roll out …

Allowing Corbevax as booster for those vaccinated with Coivishield, Covaxin likely to be considered by NTAGI
2 years, 6 months ago

Allowing Corbevax as booster for those vaccinated with Coivishield, Covaxin likely to be considered by NTAGI

The Hindu  

Allowing Biological E’s Corbevax as a booster for those fully vaccinated against COVID-19 with either Covishield or Covaxin is likely to be considered by the NTAGI, which is scheduled to meet on Tuesday, sources said. “The National Technical Advisory Group on Immunisation will discuss allowing Corbevax, which has been cleared by the DCGI, as a booster for those fully vaccinated …

Bharat Biotech Nasal Covid Vaccine's Phase 3 Trials Completed
2 years, 6 months ago

Bharat Biotech Nasal Covid Vaccine's Phase 3 Trials Completed

News 18  

Bharat Biotech on Saturday said that the clinical Phase III trials of the nasal vaccine for Covid-19 have been completed and that the company will submit its data with Drugs Controller General of India next month. Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday said, if everything is okay, then they will get permission to launch …

India to soon get its first mRNA COVID-19 vaccine: Why is this being touted as a gamechanger?
2 years, 6 months ago

India to soon get its first mRNA COVID-19 vaccine: Why is this being touted as a gamechanger?

Firstpost  

Pune-based Gennova Biopharmaceuticals COVID-19 vaccine, which is awaiting a nod from India’s drug regulators, can be stored at temperatures between 2 and 8 degree Celsius, making its availability in remote areas possible too India’s fight against COVID-19 is about to get a huge push as the country’s first mRNA-based vaccine is one step closer to getting approval. According to reported …

Corbevax gets DCGI nod as COVID-19 booster after two doses of Covishield or Covaxin
2 years, 7 months ago

Corbevax gets DCGI nod as COVID-19 booster after two doses of Covishield or Covaxin

The Hindu  

Hyderabad-based Biological E. Limited ’s COVID-19 vaccine Corbevax has been approved by the Drug Controller General of India as a heterologous COVID-19 booster dose to individuals aged 18 years and above after 6 months of administration of primary vaccination of Covaxin or Covishield vaccines for restricted use in emergency situations. ‘’Recently, BE furnished its clinical trials data to the DCGI, …

Corbevax Gets DCGI Approval As Covid-19 Vaccine Booster Dose For 18 Years And Above
2 years, 7 months ago

Corbevax Gets DCGI Approval As Covid-19 Vaccine Booster Dose For 18 Years And Above

ABP News  

New Delhi: The Drug Controller General of India approved the Corbevax Covid-19 booster as heterologous Covid-19 booster dose for adults above the age of 18 years who got their primary Covid-19 vaccination of Covishield or Covaxin administered six months before, reported news agency ANI. Recently, BE has furnished its clinical trials data to the DCGI who after a detailed evaluation …

Biological E’s Corbevax gets DCGI nod as heterologous Covid booster dose
2 years, 7 months ago

Biological E’s Corbevax gets DCGI nod as heterologous Covid booster dose

Live Mint  

Hyderabad-based pharma company Biological E. Limited on Saturday announced that its Covid-19 vaccine CORBEVAX has been approved by the Drug Controller General of India as a heterologous Covid-19 booster dose for adults. Now, individuals aged 18 years and above who have already taken two doses of either Covishield or Covaxin can now receive a dose of Corbevax as a heterologous …

Corbevax gets DCGI nod as Covid-19 booster dose
2 years, 7 months ago

Corbevax gets DCGI nod as Covid-19 booster dose

India TV News  

Highlights Biological E's Corbevax vaccine has been cleared for a booster dose for those 18 and above. The Drugs Controller General Of India had earlier approved Corbevax, India's first indigenously developed RBD protein subunit vaccine, for restricted use in emergency situations for those aged five and above.A press release from the vaccine maker said the Corbevax can be administered as …

India’s ‘other’ COVID vaccines: Status of under-trial & approved but unused jabs
2 years, 7 months ago

India’s ‘other’ COVID vaccines: Status of under-trial & approved but unused jabs

The Hindu  

As India nears the 200-crore COVID-19 vaccination mark, Serum Institute of India’s Covishield accounts for 80 per cent of the jabs, while Bharat Biotech’s Covaxin accounts for 16.75 per cent jabs. As of date, India has granted emergency usage authorisation to nine COVID-19 vaccine candidates in total – Covishield, Covaxin, Covovax, Corbevax, Zydus Cadila’s ZyCoV-D, Moderna’s Spikevax, Sputnik-V, Sputnik Light, …

Hyderabad-based CCMB announces first potential mRNA COVID vaccine
2 years, 7 months ago

Hyderabad-based CCMB announces first potential mRNA COVID vaccine

Firstpost  

Dr N Madhusudan Rao, CEO of Atal Incubation Centre at Centre for Cellular and Molecular Biology, said the mRNA platform has an advantage of flexibility unlike other vaccine platforms New Delhi: Dr N Madhusudan Rao, CEO-Atal Incubation Centre at Centre for Cellular and Molecular Biology on Monday said that India has developed mRNA technology against the COVID-19. The Hyderabad-based Centre …

India develops first mRNA vaccine technology to fight Covid-19
2 years, 7 months ago

India develops first mRNA vaccine technology to fight Covid-19

India Today  

India’s first indigenous mRNA vaccine technology to fight against Covid-19 has been developed by the Centre for Cellular and Molecular Biology and Council Of Scientific And Industrial Research. CSIR-Centre for Cellular and Molecular Biology is leading the development of mRNA vaccine technology in India. However, we lack the potent mRNA vaccine technology, as developed by Moderna or Pfizer/BioNtech to combat …

Discover Related